Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 22,774 | 20,321 | 18,606 | 18,660 | 16,036 |
| Operating Income | -22,774 | -20,321 | -18,606 | -18,660 | -16,036 |
| Other Income | 2 | 6 | 10 | 367 | 290 |
| Pre-tax Income | -22,772 | -20,315 | -18,596 | -18,293 | -15,746 |
| Net Income Continuous | -22,772 | -20,315 | -18,596 | -18,293 | -15,746 |
| Net Income | $-22,772 | $-20,315 | $-18,596 | $-18,293 | $-15,746 |
| EPS Basic Total Ops | -14.99 | -14.99 | -13.49 | -13.49 | -14.99 |
| EPS Basic Continuous Ops | -16.06 | -14.31 | -13.10 | -13.73 | -13.96 |
| EPS Diluted Total Ops | -14.99 | -14.99 | -13.49 | -13.49 | -14.99 |
| EPS Diluted Continuous Ops | -16.06 | -14.31 | -13.10 | -13.73 | -13.96 |
| EBITDA(a) | $-22,354 | $-20,003 | $-18,358 | $-18,518 | $-15,860 |